Aurobindo Pharma - The Bulls Wire

Aurobindo pharma approves Fourth interim dividend of 450% per share.

Team Bullswire

June 9, 2022June 9, 2022

The Board of Directors of Aurobindo Pharma Ltd has approved fourth interim dividend of 450% i.e Rs.4.50 (Rupees four and paise fifty) per equity share...

Breaking News

Soli Merwan Cama: The Visionary Producer Redefining Bollywood’s Global Footprint

Dr. Shibani Staney Honored as Midday Powerful Women Icon 2025

Nimaaya Women’s Centre for Health organises ‘Nimaaya GR8 Run’ on Women’s Day

Abhijeeth Bhattacharjee and Sangitanjaly Foundation Celebrates International Women’s Day in Hyderabad

Numax: Team Sunil Goel Celebrates India’s Champions Trophy Win with Associates from Gwalior and Muzaffarnagar

Tanaji Bhimaji Gargote Crowned IRG Champion at South Asia’s First Mind Sports Championship’s West Zone Finals

Super Iron Foundry Ltd plans to raise up to Rs. 68.05 crore from Public Issue; IPO opens on March 11

Parvati Jangid Suthar: The ‘Sister of Soldiers’ Named Among World’s Most Extraordinary Women by Harvard100

Robin Uthappa’s Amazing Cricket Predictions Inspires Champions to Write New Script of Resurgence

Satyam Fashion Institute Hosts Satyam’s Triptych 2025: A Grand Showcase of Design Creativity

Aurobindo pharma approves Fourth interim dividend of 450% per share.